Helene Peyro-Saint-Paul, MD, Chief Medical Officer of PathoQuest provides an overview of the development, validation and clinical evaluation of the iDTECT™ Blood Test. This test uses a next-genome sequencing (NGS) shotgun metagenomics approach and is CE-IVD marked to detect pathogens in blood samples, especially in immunocompromised patients.

View related videos

• Next-Generation Sequencing Technology Drives Discoveries in Disease Pathology 

View related information 

Subscribe to the Illumina video channel

For In Vitro Diagnostic Use.